公司概覽
業務類別 Biotechnology
業務概覽 Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
公司地址 50 Broadway, 7th Floor, London, GBR, SW1H 0BD
電話號碼 +44 2074003347
傳真號碼 --
公司網頁 https://www.roivant.com
員工數量 721
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Frank M. Torti, M.D. Co-President 美元 725.00K 29/07/2026
Dr. Eric Venker, M.D.,Pharm.D. Co-President; Chief Executive Officer, Immunovant 美元 75.00K 29/07/2026
Mr. Matthew Gline Chief Executive Officer and Director 美元 725.00K 29/07/2026
Dr. Mayukh Sukhatme Co-President, Chief Investment Officer and Director 美元 550.00K 29/07/2026
Mr. Richard Pulik Chief Financial Officer 美元 450.88K 29/07/2026
Ms. Jennifer Humes Chief Accounting Officer; Chief Accounting Officer of Roivant Sciences, Inc. -- 29/07/2026
 
董事會成員
董事會 職務 更新日期
Mr. James C. Momtazee Independent Director 29/07/2026
Dr. Meghan M. Fitzgerald, Ph. Independent Director 29/07/2026
Mr. Keith Manchester, M.D. Independent Director 29/07/2026
Mr. Ilan Oren Chairman of the Board 29/07/2026
Ms. Melissa B. Epperly Independent Director 29/07/2026
Mr. Daniel Gold Independent Director 29/07/2026
Mr. Matthew Gline Chief Executive Officer and Director 29/07/2026
Dr. Mayukh Sukhatme Co-President, Chief Investment Officer and Director 29/07/2026
 
所屬ETF (更新日期: 11/11/2026 03:45)
代號 名稱 佔比% ▼ 持有日期
BMEZBlackRock Health Sciences Term Trust0.06%30/06/2026
VTVanguard Total World Stock ETF0.06%30/09/2026
QQQJInvesco NASDAQ Next Gen 100 ETF0.06%30/10/2026
PDPInvesco Dorsey Wright Momentum ETF0.06%30/10/2026
MDYVState Street® SPDR® S&P 400™ Md CpValETF0.05%30/10/2026
IWBiShares Russell 1000 ETF0.05%30/10/2026
IYHiShares US Healthcare ETF0.05%30/10/2026
VONVVanguard Russell 1000 Value ETF0.05%30/09/2026
SCHBSchwab US Broad Market ETF™0.05%31/10/2026
IVOGVanguard S&P Mid-Cap 400 Growth ETF0.04%30/09/2026
PTHInvesco Dorsey Wright Healthcare MomtETF0.04%30/10/2026
SMMDiShares Russell 2500 ETF0.04%30/10/2026
TMSLT. Rowe Price Small-Mid Cap ETF0.04%31/10/2026
DFUVDimensional US Marketwide Value ETF0.04%30/10/2026
IUSGiShares Core S&P US Growth ETF0.04%30/10/2026
SCHVSchwab US Large-Cap Value ETF™0.04%31/10/2026
FHLCFidelity MSCI Health Care ETF0.04%30/10/2026
JHMMJHancock Multifactor Mid Cap ETF0.03%30/10/2026
ADPVAdaptiv™ Select ETF0.03%30/10/2026
PRFZInvesco RAFI US 1500 Small-Mid ETF0.03%30/10/2026
  1   2    3    4    5    6    7    8    9  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.